Gilead Sciences, Inc. - Insider Trading & Ownership
-
Location
-
333 Lakeside Dr, Foster City, CA
-
Summary
-
The estimated value of insider holdings of Gilead Sciences, Inc. is at least $894M dollars as of December 1, 2025. Gilead Sciences, Inc. is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $371M. Gilead Sciences, Inc. is the 10%+ Owner of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $346M. Gilead Sciences, Inc. is the 10%+ Owner of ASSEMBLY BIOSCIENCES, INC. and owns shares of ASSEMBLY BIOSCIENCES, INC. (ASMB) stock worth about $100M. Gilead Sciences, Inc. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $36.9M. Gilead Sciences, Inc. is the 10%+ Owner of LEAP THERAPEUTICS, INC. and owns shares of LEAP THERAPEUTICS, INC. (LPTX) stock worth about $15.2M. Gilead Sciences, Inc. is the 10%+ Owner of HOOKIPA Pharma Inc. and owns shares of HOOKIPA Pharma Inc. (HOOK) stock worth about $13.6M. Gilead Sciences, Inc. is the 10%+ Owner of Allovir, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $11.2M.
-
Signature
-
Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
Notify me when Gilead Sciences, Inc. files a new Insider Trading report.
⭐ Subscribe ⭐